Drawing for ONSANDA

USPTO serial 79295640

ONSANDA

Reviewed by CopyMark Law Group

Reg. 6481102Status 700Renewal
Filing date
Status date
Registration date
Sep 14, 2021
Examiner
TERRELL, MARIESSA REBECCA
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ONSANDA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*

Plus Government fees of $325

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC3724 BENSON DRRALEIGH, NC 27609UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculoskeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthmaACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 21, 2022FINVFINAL DECISION TRANSACTION PROCESSED BY IB
Mar 1, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB
Feb 28, 2022FIMPFINAL DISPOSITION PROCESSED
Dec 14, 2021FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 14, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 29, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 29, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jun 9, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 24, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Mar 24, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Mar 24, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 24, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 30, 2021RFNTREFUSAL PROCESSED BY IB
Dec 29, 2020RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Dec 28, 2020RFRRREFUSAL PROCESSED BY MPU
Dec 15, 2020RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 14, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 10, 2020DOCKASSIGNED TO EXAMINER
Nov 2, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 2, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 2, 2020ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Nov 2, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 2, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 2, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 24, 2020MAFRAPPLICATION FILING RECEIPT MAILED
Oct 20, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 19, 2020LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED
Oct 8, 2020SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB

Frequently asked questions

Related guidance